BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vetrugno V, Puopolo M, Cardone F, Capozzoli F, Ladogana A, Pocchiari M. The future for treating Creutzfeldt–Jakob disease. Expert Opinion on Orphan Drugs 2014;3:57-74. [DOI: 10.1517/21678707.2015.994605] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Luiz Henrique Lélis Miranda, André Felipe Pastick de Holanda Oliveira, Davi Mariano de Carvalho, Gustavo Marques Figueredo Souza, João Guilherme Monteiro Magalhães, Joselmo Alberto Cabral, Pedro Thadeu Mertens Brainer de Queiroz Lima, Renato Melo Aguiar, Sérgio Pereira Lins, Hugo Moura de Albuquerque Melo. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far? Arq Neuropsiquiatr;80. [PMID: 36252593 DOI: 10.1055/s-0042-1755341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sheshe SM. Creutzfeldt-Jakob Disease. Research Anthology on Diagnosing and Treating Neurocognitive Disorders 2021. [DOI: 10.4018/978-1-7998-3441-0.ch003] [Reference Citation Analysis]
3 Sheshe SM. Creutzfeldt-Jakob Disease. Advances in Medical Diagnosis, Treatment, and Care 2019. [DOI: 10.4018/978-1-5225-5282-6.ch017] [Reference Citation Analysis]
4 Pocchiari M, Manson J. Concluding remarks. Human Prion Diseases 2018. [DOI: 10.1016/b978-0-444-63945-5.00028-3] [Reference Citation Analysis]
5 Ladogana A, Kovacs GG. Genetic Creutzfeldt-Jakob disease. Handb Clin Neurol 2018;153:219-42. [PMID: 29887139 DOI: 10.1016/B978-0-444-63945-5.00013-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
6 Redaelli V, Tagliavini F, Moda F. Clinical features, pathophysiology and management of fatal familial insomnia. Expert Opinion on Orphan Drugs 2017;5:397-404. [DOI: 10.1080/21678707.2017.1311251] [Reference Citation Analysis]
7 Pasha S. Case Report of Clinically Probable Sporadic Creutzfeldt - Jakob Disease from A Tertiary Care Hospital in South India. Ann Alzheimers Dement Care 2017;1:013-017. [DOI: 10.17352/aadc.000003] [Reference Citation Analysis]
8 Gandini A, Bolognesi ML. Therapeutic Approaches to Prion Diseases. Progress in Molecular Biology and Translational Science 2017. [DOI: 10.1016/bs.pmbts.2017.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
9 Pocchiari M, Ladogana A. Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2015;86:705. [PMID: 25632154 DOI: 10.1136/jnnp-2014-310127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]